Atlas Trials

Botulinum Toxin for Trigeminal Neuralgia

Clinical trial NCT03331913 · UNKNOWN

Trial details

NCT number
NCT03331913
Sponsor
The First Affiliated Hospital of Zhengzhou University
Status
UNKNOWN
Phase
Phase 3
Study type
INTERVENTIONAL
Trigeminal Neuralgia
Start date
2017-11-07
Primary completion
2019-02-28
Enrollment
150

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.